K
Kyverna Therapeutics Inc
NASDAQ:KYTX
Kyverna Therapeutics Inc
NASDAQ:KYTX
Price:
8.39
USD
-5.41%
Market Closed
Market Cap:
$479.3m
Cash Flow Statement
Cash Flow Statement
Kyverna Therapeutics Inc
Kyverna Therapeutics Inc
Currency:
| Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
(60)
|
(87)
|
(116)
|
(111)
|
(127)
|
(145)
|
(159)
|
(161)
|
|
| Depreciation & Amortization |
2
|
2
|
3
|
2
|
2
|
2
|
2
|
2
|
|
| Stock-Based Compensation |
2
|
5
|
6
|
8
|
8
|
8
|
9
|
9
|
|
| Other Non-Cash Items |
3
|
5
|
5
|
4
|
3
|
2
|
4
|
5
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
3
|
2
|
6
|
9
|
8
|
8
|
11
|
(3)
|
|
| Cash from Operating Activities |
(52)
N/A
|
(78)
-50%
|
(102)
-31%
|
(96)
+7%
|
(114)
-19%
|
(133)
-17%
|
(141)
-6%
|
(157)
-11%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(1)
|
(1)
|
(2)
|
(2)
|
(2)
|
(2)
|
(1)
|
(1)
|
|
| Other Items |
(8)
|
(130)
|
(197)
|
(156)
|
(159)
|
(31)
|
65
|
88
|
|
| Cash from Investing Activities |
(9)
N/A
|
(132)
-1 400%
|
(200)
-52%
|
(158)
+21%
|
(161)
-2%
|
(32)
+80%
|
65
N/A
|
87
+33%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
61
|
402
|
402
|
342
|
341
|
0
|
0
|
2
|
|
| Net Issuance of Debt |
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
|
| Other |
(2)
|
(5)
|
(5)
|
(5)
|
(3)
|
(0)
|
(0)
|
(1)
|
|
| Cash from Financing Activities |
58
N/A
|
396
+582%
|
395
0%
|
336
-15%
|
337
+0%
|
(1)
N/A
|
(1)
+27%
|
0
N/A
|
|
| Change in Cash | |||||||||
| Net Change in Cash |
(3)
N/A
|
186
N/A
|
93
-50%
|
82
-12%
|
62
-24%
|
(167)
N/A
|
(77)
+54%
|
(71)
+9%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
(53)
N/A
|
(80)
-50%
|
(105)
-31%
|
(98)
+7%
|
(116)
-19%
|
(135)
-16%
|
(142)
-5%
|
(158)
-12%
|
|
Switch to:
Switch to:
See Also
Discover More
